Tepotinib in patients (pts) with advanced non-small cell lung cancer (NSCLC) with MET amplification (METamp).

被引：37

作者：

Le, Xiuning

Paz-Ares, Luis G.

Van Meerbeeck, Jan

Viteri, Santiago

Galvez, Carlos Cabrera

Baz, David Vicente

Kim, Young-Chul

Kang, Jin-Hyoung

Schumacher, Karl-Maria

Karachaliou, Niki

Adrian, Svenja

Bruns, Rolf

Paik, Paul K.

机构：

[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[2] Hosp Univ 12 Octubre, Madrid, Spain

[3] Antwerp Univ Hosp UZA, Edegem, Belgium

[4] Dexeus Univ Hosp, Dr Rosell Oncol Inst, Quiron Salud Grp, Barcelona, Spain

[5] Hosp Univ Sagrat Cor, Barcelona, Spain

[6] Hosp Univ Virgen Macarena, Serv Oncol, Seville, Spain

[7] Chonnam Natl Univ, Hwasun Hosp 13868, Hwasun Gun, South Korea

[8] Catholic Univ Korea, Seoul St Marys Hosp, Seoul, South Korea

[9] Merck KGaA, Global Clin Dev, Darmstadt, Germany

[10] Merck KGaA, Darmstadt, Germany

[11] Merck KGaA, Dept Biostat, Darmstadt, Germany

[12] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

来源：

关键词：

D O I：

10.1200/JCO.2021.39.15_suppl.9021

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

9021

引用

页数：3